Adaptate is a biotechnology company which spun-out from GammaDelta Therapeutics in 2019. Adaptate is focused on developing therapeutic antibodies to drug targets to modulate the activity of gamma delta T cells. The company has received investment from Abingworth and Takeda Pharmaceutical Company, with support from King’s College London, the Francis Crick Institute and Cancer Research Technology
Location: United Kingdom, England, London
Member count: 11-50
Total raised: $18M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 19.04.2021 | - | $18M | - | cambridgen... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 19.04.2021 | Seagen get... | Seagen is riding the wave of ... | - | Max Gelman | endpts.com... |
| 19.04.2021 | Adaptate B... | Adaptate Biotherapeutics raise... | - | - | cambridgen... |
| 19.04.2021 | Adaptate B... | London, UK... Adaptate Biother... | - | - | cambridgen... |